Insiders · Profile

Jenne Kyle

EVP, Chf GL Pdt Str Ofcr at IONIS PHARMACEUTICALS. Filing since 16 Apr 2025. CIK 0001791857

Company
Date
Role
Action
Shares
Amount
Of holding
16 Apr 2026
EVP, Chf GL Pdt Str Ofcr
Sold at will
4,902
$368.49K
17.1%
10 Mar 2026
EVP, Chf GL Pdt Str Ofcr
Sold on a plan
37,277
$2.83M
76.1%
16 Jan 2026
EVP, Chf GL Pdt Str Ofcr
Sold at will
1,823
$138.48K
10.0%
16 Apr 2025
EVP, Chf GL Pdt Str Ofcr
Sold at will
3,016
$85.53K
21.2%
4 decisions on file.